Led by gains in Divi’s Labs, Sun Pharma, Cadila Healthcare, and Dr Reddy’s Laboratories, the Nifty Pharma pack was trading marginally higher in Wednesday’s trade,...
Dr Reddy’s Laboratories on Monday announced the commercial launch of the anti-Covid drug 2-deoxy-D-glucose (2-DG), developed in collaboration with the Defence Research and Development Organisation...
Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday launched the first batch of Anti-COVID drug 2-deoxy-D-glucose developed by the Defence...
Indian benchmark equity indices ended higher on Monday for the fourth straight session tracking positive from global markets. Sensex ended at 47,353.75, up 380.21 points...
On Wednesday’s morning session, Pharma shares were trading lower with their sectoral index trading lower. Shares of Cadila Healthcare down by 0.47 per cent, Dr...
Pharmaceutical major Dr. Reddy’s Laboratories Ltd witnessed a highly volatile day as the company’s stock tumbled as much as 29.78 per cent during the Friday...
Dr Reddy’s Laboratories Limited posted their quarterly financial report with a profit after tax at Rs 504 crores, surging 77%for the quarter ended September 30,...
Hyderabad-based pharmaceutical giant, Dr Reddy’s Laboratories Ltd, has announced that Promius Pharma, LLC, its wholly owned subsidiary has sold its rights of Cloderm Cream, 0.1%...
Dr Reddy’s Laboratories Ltd has launched Clofarabine Injection, in the United States market, a remedy which is identical generic version of Clolar (clofarabine) Injection. The generic version of the injection is...